A citation-based method for searching scientific literature

D A Stoffers, T J Kieffer, M A Hussain, D J Drucker, S Bonner-Weir, J F Habener, J M Egan. Diabetes 2000
Times Cited: 453



Yazhou Li, Xiemin Cao, Li-Xin Li, Patricia L Brubaker, Helena Edlund, Daniel J Drucker. Diabetes 2005
Times Cited: 152




List of shared articles



Times cited

The New Biology and Pharmacology of Glucagon.
T D Müller, B Finan, C Clemmensen, R D DiMarchi, M H Tschöp. Physiol Rev 2017
116

GLP-1 signalling compensates for impaired insulin signalling in regulating beta cell proliferation in βIRKO mice.
Dan Kawamori, Jun Shirakawa, Chong Wee Liew, Jiang Hu, Tomoaki Morioka, Alokesh Duttaroy, Bryan Burkey, Rohit N Kulkarni. Diabetologia 2017
21

The regulation of function, growth and survival of GLP-1-producing L-cells.
Rune E Kuhre, Jens J Holst, Camilla Kappe. Clin Sci (Lond) 2016
21

Glucagon-Like Peptide 1 Analogs and their Effects on Pancreatic Islets.
Eva Tudurí, Miguel López, Carlos Diéguez, Angel Nadal, Rubén Nogueiras. Trends Endocrinol Metab 2016
32

GLP-1 Receptor Agonists and Type 1 Diabetes - Where Do We Stand?
Djordje S Popovic, Edita Stokic, Stevan L Popovic. Curr Pharm Des 2015
4


Incretins: their physiology and application in the treatment of diabetes mellitus.
Hale M Tasyurek, Hasan Ali Altunbas, Mustafa Kemal Balci, Salih Sanlioglu. Diabetes Metab Res Rev 2014
53


Long-term treatment with EXf, a peptide analog of Exendin-4, improves β-cell function and survival in diabetic KKAy mice.
Guo-jiang Hou, Cai-na Li, Shuai-nan Liu, Yi Huan, Quan Liu, Su-juan Sun, Lin-yi Li, Shao-cong Hou, Zhu-fang Shen. Peptides 2013
9

GLP-1 agonists in type 1 diabetes.
Jeremy Pettus, Irl Hirsch, Steven Edelman. Clin Immunol 2013
29